Cite
APA Citation
Yiu, T. H., Leong, R., Ko, Y., & Pudipeddi, A. (n.d.). p564 vedolizumab versus infliximab and adalimumab in the real-world persistence in Ulcerative Colitis and Crohn's disease – a meta-analysis. Journal of Crohn's and colitis, 17, i694–i695. http://access.bl.uk/ark:/81055/vdc_100179843701.0x000012